Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|February 3, 2005
Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody constructPatrick Hoffmann, Robert Hofmeister, Klaus Brischwein, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2005
Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapySonja Offner, Armin Hekele, Ulrike Teichmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2012
The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell cultureAlexander Hoh, Alexander Dewerth, Fabian Vogt, et al.
Plos One|August 25, 2017
Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killingSandra L Ross, Marika Sherman, Patricia L McElroy, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 21, 2005
Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinomaKai Breuhahn, Patrick A Baeuerle, Malte Peters, et al.
Molecular Immunology|August 17, 2005
High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin GSusanne Preithner, Stefanie Elm, Sandra Lippold, et al.
International Journal of Cancer|September 5, 2002
Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibodyTorsten Dreier, Grit Lorenczewski, Christian Brandl, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2006
A phase I study with adecatumumab, a human antibody directed against epithelial cell adhesion molecule, in hormone refractory prostate cancer patientsRalf Oberneder, Dorothea Weckermann, Beatrice Ebner, et al.
Antiviral Research|March 5, 2017
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infectionJochen Pendzialek, Kenny Roose, Anouk Smet, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2011
Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cellsHitoe Torisu-Itakura, Hans F Schoellhammer, Myung-Shin Sim, et al.
Pageof 10